Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevel Collect Regulatory News (RBG)

  • There is currently no data for RBG

Form 8 (OPD) (Nightcap plc)

17 May 2024 07:00

RNS Number : 8132O
Nightcap PLC
17 May 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Nightcap plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Nightcap plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

16 May 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests in Nightcap plc's ordinary shares held by the directors of Nightcap plc and their close relatives, related trusts, concert parties and connected advisers

 

Name

Number of ordinary shares held

Percentage of voting share capital

Sarah Willingham-Toxvaerd

21,686,584

9.25%

Michael Willingham-Toxvaerd

12,552,501

5.35%

Tobias Van der Meer

9,050,000

3.86%

Lance Moir

360,000

0.15%

Thi-Hanh Jelf

180,000

0.08%

John James Goodman

15,130,845

6.45%

Ava Goodman(1)

1,621,162

0.69%

CGCC Ltd(2)

901,312

0.38%

Judy Draycott

43,478

0.02%

Allenby Capital Limited (connected adviser)

500,000

0.21%

 

(1) Ava Goodman is a close relative of John James Goodman

(2) CGCC Ltd is a company which is beneficially controlled and owned by John James Goodman

 

(b) Interests of the directors of Nightcap plc in rights to subscribe for shares in Nightcap plc

 

Options over ordinary shares in Nightcap plc

 

Name

Date of grant

Exercise price (p)

Expiry Date

Number Outstanding

Sarah Willingham-Toxvaerd(3)

13 January 2021

10

13 January 2031

6,000,000

Michael Willingham-Toxvaerd(3)

13 January 2021

10

13 January 2031

2,500,000

John James Goodman(3)

13 January 2021

10

13 January 2031

1,400,000

 

(3) Details of the vesting criteria of these share options can be found in Nightcap plc's admission document published on 7 January 2021

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

17 May 2024

Contact name:

Richard Haley

Email address:

email@nightcapplc.com

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAXSKFLFLEFA
Date   Source Headline
5th Jan 20247:00 amRNSTrading and Estate Update
22nd Dec 20237:00 amRNSHolding(s) in Company
21st Dec 202310:40 amRNSHolding(s) in Company
18th Dec 202312:30 pmRNSHolding(s) in Company
14th Dec 20233:59 pmRNSHolding(s) in Company
12th Dec 202310:58 amRNSHolding(s) in Company
5th Dec 20233:20 pmRNSHolding(s) in Company
30th Nov 202311:58 amRNSResult of the 2023 Annual General Meeting
24th Nov 202310:00 amRNSHolding(s) in Company
21st Nov 202311:18 amRNSDealing by Director/PDMR
7th Nov 202310:14 amRNSPublication of 2023 Annual Report & Accounts/AGM
7th Nov 20237:00 amRNSPublication of 2022 Annual Report & Accounts/AGM
2nd Nov 20237:00 amRNSHolding(s) in Company
27th Oct 20237:00 amRNSGrant of Options
26th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
17th Oct 20237:00 amRNSPreliminary results
26th Jul 20237:00 amRNSPre-Close Statement
24th Jul 202310:30 amRNSNotification of Trading Update
15th Mar 20233:00 pmRNSDirector/PDMR Shareholding
7th Mar 20239:05 amRNSSecond Price Monitoring Extn
7th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSInterim Results
9th Feb 20234:40 pmRNSSecond Price Monitoring Extn
9th Feb 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSH1 Trading Update
2nd Dec 20221:53 pmRNSResult of AGM
9th Nov 20222:38 pmRNSPublication of 2022 Annual Report & Accounts/AGM
26th Oct 20227:00 amRNSGrant of Options
18th Oct 20226:02 pmRNSPreliminary Results
18th Oct 20226:01 pmRNSAcquisition of Peach Pub Company
18th Oct 20227:00 amRNSDelayed publication of Preliminary results
2nd Aug 20227:00 amRNSPre Close Statement
14th Jun 20227:00 amRNSTrading and Property Update
1st Mar 20227:00 amRNSInterim Results
21st Feb 20221:38 pmRNSNotice of Interim Results
20th Jan 20227:00 amRNSH1 Trading Update
19th Jan 202212:42 pmRNSNotification of H1 Trading Update
22nd Dec 20211:40 pmRNSResult of AGM
26th Nov 20215:55 pmRNSPublication of Annual Report and AGM Circular
24th Nov 20217:55 amRNSGrant of Options
16th Nov 20217:00 amRNSPreliminary Results
7th Oct 20217:00 amRNSTrading Update and Notice of Results
4th Oct 20218:32 amRNSHolding(s) in Company
23rd Sep 20218:12 amRNSHolding(s) in Company
28th Jul 20219:05 amRNSSecond Price Monitoring Extn
28th Jul 20219:00 amRNSPrice Monitoring Extension
1st Jul 20219:00 amRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSTrading Update
28th Jun 20219:35 amRNSHolding(s) in Company
22nd Jun 20214:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.